Risk of cancer after herpes zoster: a population-based study

The New England Journal of Medicine
M W RagozzinoH O Perry

Abstract

Herpes zoster has been associated with immune suppression, as has an increased risk of cancer. To determine whether patients with herpes zoster are at increased risk for subsequent cancer, we followed 590 residents of Rochester, Minnesota, for 9389 person-years after the diagnosis of herpes zoster. Subsequent relative cancer risks, overall and by specific site, were determined for the entire cohort and selected subgroups. In addition, relative risks of cancer during various intervals after the diagnosis of herpes zoster were determined. The overall relative risk was 1.1 (95 per cent confidence interval, 0.9 to 1.3). Relative risks of specific cancer sites were not different from unity except for those for colon and bladder tumors in women, both of which were slightly elevated. Patients with disseminated, recurrent, or gangrenous zoster, with postherpetic neuralgia, and with ophthalmic zoster wee not at elevated risk for subsequent cancer. These findings do not support the investigation of patients for occult cancer at the time of diagnosis of herpes zoster or enhanced surveillance for cancer after such a diagnosis.

References

Mar 15, 1977·American Journal of Obstetrics and Gynecology·T W McDonaldL T Kurland
Sep 1, 1978·Annals of Internal Medicine·R DolinR J Whitley
Feb 1, 1979·Cancer·J F AnnegersW M O'Fallon
Feb 1, 1979·American Journal of Epidemiology·E S MaramD D Brian
Nov 8, 1976·JAMA : the Journal of the American Medical Association·A R Rhodes
Mar 1, 1973·Cancer·A P LanierL T Kurland
Apr 1, 1974·American Journal of Epidemiology·N MaruchiL R Elveback
Jan 1, 1971·Transplantation Reviews·F M Burnet
Jun 1, 1971·Journal of Chronic Diseases·R B ByrdL T Kurland
Jan 1, 1966·Gerontologia Clinica·L Hellgren, K Hersle
Nov 5, 1955·British Medical Journal·R WYBURN-MASON
Jan 12, 1957·British Medical Journal·R M MCGREGOR
Feb 1, 1957·A.M.A. Archives of Dermatology·J M DE MORAGAS, R R KIERLAND
May 1, 1964·Archives of Internal Medicine·J G MERSELISE W HOOK

❮ Previous
Next ❯

Citations

May 20, 2003·Dermatology Nursing·Elizabeth J Roberts, Barbara Heitman
Mar 1, 1984·The American Journal of Medicine·K K Wong, M S Hirsch
Sep 1, 1989·Mayo Clinic Proceedings·P N NemetzL T Kurland
Jul 20, 1999·Journal of the American Academy of Dermatology·M L McCraryS K Tyring
Jan 15, 2004·The Lancet Infectious Diseases·Sara L Thomas, Andrew J Hall
Nov 13, 2001·International Journal of Dermatology·R Bansal
Dec 30, 1982·The New England Journal of Medicine·T J McManusC S Easmon
Aug 2, 2002·The New England Journal of Medicine·John W Gnann, Richard J Whitley
Nov 5, 1998·The Pediatric Infectious Disease Journal·G PeturssonJ A Sigurdsson
Jul 30, 2005·Journal of General Internal Medicine·Ralph P InsingaAlexander A Nikas
Sep 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·P N NemetzL T Kurland
May 1, 1987·The British Journal of Ophthalmology·S P HardingJ C Wells
Jul 16, 2005·BMJ : British Medical Journal·Wim Opstelten, Michel J W Zaal
May 9, 2006·Postgraduate Medical Journal·P D Welsby
Jan 1, 1996·Annual Review of Microbiology·A M Arvin, A A Gershon
Sep 19, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Yu-Ping WangChang-Phone Fung
Apr 17, 2007·Médecine sciences : M/S·Benjamin Silbermann, Odile Launay
Jan 1, 1997·Cancer Investigation·M M Hanania, D Brietstein
Sep 1, 1984·Journal of the American Academy of Dermatology·M A Fueyo, D P Lookingbill
Nov 1, 1984·Journal of the American Geriatrics Society·J P Harnisch
Apr 3, 2013·Journal of Epidemiology·Hui-Fen ChiuChun-Yuh Yang
Sep 22, 2000·Current Review of Pain·E Lojeski, R A Stevens
May 20, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kunihiro Yamaoka
Oct 1, 2016·Indian Journal of Dermatology·Bhumesh Kumar KatakamUdaya Kumar
Apr 1, 1990·Journal of the American Academy of Nurse Practitioners·T Boley, J Curtis
Jul 18, 2002·Dermatologic Clinics·T Minsue ChenSylvia Hsu
Apr 1, 1987·Annals of Emergency Medicine·M R Sayre, E J Lucid
Oct 14, 2017·Expert Opinion on Pharmacotherapy·John Schutzer-Weissmann, Paul Farquhar-Smith
Sep 13, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·G BezoldR U Peter
Aug 8, 2018·Annals of Internal Medicine·Kenneth Schmader
Jun 27, 2015·Cornea·Elisabeth J Cohen
Dec 21, 2006·Pain Practice : the Official Journal of World Institute of Pain·David Niv, Alexander Maltsman-Tseikhin
Dec 1, 1986·Annals of Neurology·R K PortenoyK M Foley
Jan 1, 1987·Postgraduate Medicine·B J Murray
Feb 1, 1989·Postgraduate Medicine·H A Brings
Aug 1, 1986·Journal of the Royal Society of Medicine·J A Savin
Nov 23, 2000·Cancer Control : Journal of the Moffitt Cancer Center·E A Burns, E A Leventhal
Nov 1, 1983·Journal of the American Geriatrics Society·K O Goh, T F Williams
Nov 19, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Parag MahaleEric A Engels

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.